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Objective To study the effect of bone defect augmentation on the dynamics of bone remodeling markers. Material and 
methods The effect of resorbable xenoplastic material (RXM), synthetic beta-tricalcium phosphate (b-TCP), porous titanium 
implant (PTI) and nanostructured carbon implant (NCI) on the markers of bone remodeling (osteocalcin, OC; bone alkaline 
phosphatase, BALP; C-terminal telopeptide of type I collagen, CTX-1) and inflammation marker (C-reactive protein, CRP) 
was investigated using bone defect model in rabbits. 24 animals were divided into 4 groups (n = 6 in each group) according 
to the type of osteoplastic material. Control group (n = 6) was without augmentation. An impression fracture of the proximal 
tibia was modeled. Blood samples were taken on days 1, 3, 7, 14, 45, 90, 180 after surgery. Results CTX-1was not detected 
in the control, b-TCP, PTI, and RXM groups after 90 days, but in the NCI group CTX-1 remained elevated until the end of 
the study. OC in the control, b-TCP, PTI groups reached a maximum at 14-45 days. No significant increase in OC was found 
in the NCI group. The BALP in the control group peaked at 90 days. In the b-TCP and PTI groups the concentration of BALP 
increased more rapidly. The dynamics of CRP in the RXM, b-TCP and PTI groups was similar to the dynamics in the control 
group, in the NCI group an increased level of CRP remained until the end of the study. Conclusion When a bone defect was 
augmented with both resorbable b-TCP and non-resorbable PTI, high osteogenesis activity and low osteoresorption activity 
were detected. The use of xenoplastic material did not reveal any advantages in comparison with surgery performed without 
augmentation. An increase in osteoresorption and a low level of osteogenesis were found by using NCI.
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INTROdUCTION
Substitution (augmentation) of bone defects refers 
to the priorities of current clinical medicine. Bone 
defects occur in the surgical treatment of intra- and 
periarticular fractures, partial osteochondral defects, 
in degenerative diseases of large joints of the limb 
bones and oncopathology of the musculoskeletal 
system [1, 2]. The need for surgical management of 
a bone defect necessitates a constant search for new 
materials and structures for osteoplasty that can be 
successfully integrated into the human body, have 
good biocompatibility and the ability to stimulate 
osteoconduction and osteoinduction mechanisms [3].
Currently, there is a wide range of replacement 
materials for osteoplasty of a bone defect [4–6]. Non-
mineralized xenomaterial is obtained from purified 
animal bones, which are processed to a highly purified 
bone matrix, resulting in the preservation of collagen 
and mineral components [7]. Another resorbable 
osteoplastic material is synthetic β-tricalcium phosphate, 
the porous structure of which supports osteoblasts and 
promotes the integration of bone tissue. Small size of the 
particles improves the osteoconductive properties of the 
augment and ensures its integration during the process 
of bone remodeling [8]. Titanium is one of the most 
inert and biotolerant metals, which has a widespread 
use in traumatology and orthopedics [9]. Selective laser 
melting technology allows obtaining titanium augments 
with a given architectonics [10]. Non-resorbable 
nanostructured carbon implants also have a sufficient set 
of characteristics (osteoinduction, bioinertness, safety) 
allowing their use in traumatology and orthopedics [11].
An important element of the research on the use of 
various types of augments to bone tissue is to obtain 
information about the nature and dynamics of the 
repair process. Molecular markers of bone remodeling 
have been shown to be informative both for assessing 
the effectiveness of bone repair after surgical treatment 
of fractures and for early detection of osteogenesis 
disorders. It was found that the indices of bone markers 
differ in various types of fractures and their location, 
[12–14]. However, there is no data on the features of 
bone metabolism by filling bone defects with various 
resorbable and non-resorbable augments. The aim of 
this work was a comparative study of the effect of 
various resorbable and non-resorbable materials for 
bone tissue filling on the dynamics of resorption and 
bone formation markers in a rabbit trabecular bone 
model of an impression fracture.
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MATERIAL ФТА METHOdS
Study object The study was performed on 
30 sexually mature female Chinchilla rabbits 
weighing 3–3.5 kg at the beginning of the experiment. 
The animals were kept in the vivarium of the Ural 
State Medical University, were healthy; veterinary 
certificates of quality and health status were provided. 
The study design was approved by the local ethics 
committee of the Federal State Budget Educational 
Institution of Higher Medical Education of the Ural 
State Medical University of the Russian Ministry of 
Health. The study was carried out in accordance with 
the “Guidelines for the maintenance of laboratory 
animals in vivariums of research institutes and 
educational institutions” RD-APK 3.10.07.02-09 and 
Directive 2010/63 / EU of the European Parliament 
and the Council of the European Union “On the 
Protection of Animals Used for Scientific Purposes” 
Animals were kept in identical conditions of feeding 
and maintenance. Euthanasia was performed by 
overdosing a solution of 20 % sodium thiopental.
Osteoplastic materials To fill in bone defects, 
the following materials were used: 1) resorbable 
xenoplastic material Osteomatrix, which is a chemically 
processed non-demineralized lyophilized bone matrix 
of an animal, manufactured by Connectbiopharm 
(Russia); 2) synthetic beta-tricalcium phosphate 
(β-TCP) (Science & BioMaterials, France), which is 
an osteoconductive resorbable augment with a porosity 
of 60 %; 3) porous (volume porosity of 80 %) titanium 
implants (cylindrical samples d = 5 mm, h = 5 mm) 
produced with additive technologies (3D printing), 
were experimental medical products made by direct 
laser metal sintering (dMLS) with the EOSINT-280 
system at the state corporation Rosatom (Russia); 
4) a nanostructured carbon implant, which is a hard 
composite of carbon fibers bonded by a nanostructured 
carbon matrix, cube-shaped (face size = 5 mm), 
manufactured by Nanotechmedplus (Russia).
Fracture model Interventions were performed under 
general anesthesia, 2 % rometar intramuscular injection 
of 8 mg/kg (Rometar 2 %, SPOFA, Czech Republic) 
and zoletil 6 mg/kg (Zoletil-100, Virbac Sante Animale). 
For local anesthesia, a 0.25 % novocaine solution was 
used, also for hydraulic tissue dissection. Intra-articular 
impression fracture of the proximal tibia was modelled 
according to the technique described previously in our 
works [15]. Upon modeling an impression fracture, the 
impact site was elevated, osteoplastic material of the 
“press fit” type was augmented into the defect formed, 
and the wound was sutured in layers. A day after the 
operation, the condition of the rabbits in all groups was 
satisfactory and corresponded to the early postoperative 
period. Mild edema was observed in the surgical 
intervention area for several days which did not require 
additional therapeutic measures. Postoperative wound 
healed by first intention, the sutures were removed on 
the 10th day after the operation.
Study designs All animals were divided into 
5 groups, six rabbits in each. Animals of four 
experimental groups underwent bilateral modeling 
of an impression fracture of the trabecular bone with 
subsequent augmentation by resorbable xenoplastic 
material (RXM); synthetic beta-tricalcium 
phosphate (β-TCP); porous titanium augment (PTI); 
nanostructured carbon implant (NCI). As a control 
group (CG), we used rabbits that simulated a fracture 
without subsequent surgical correction. Peripheral 
venous blood was taken in the morning from the 
marginal vein of the ear before surgery, on days 1, 3, 
7, 14, 45, 90, 180 after the operation.
Immunochemical study Blood samples were 
collected in Improvacuter vacuum tubes (China). 
Animal blood serum was obtained by precipitation after 
centrifugation of blood (3000 rpm, 20 minutes), poured 
into aliquots and stored at -70 °C until the study. To 
study the dynamics of markers of bone remodeling and 
inflammation in peripheral blood serum, concentration 
of C-terminal telopeptides (C-CT), osteocalcin (OC), 
bone isoenzyme of alkaline phosphatase (BALP), 
C-reactive protein (CRP) were determined using kits 
of enzyme-linked immunosorbent assay kit (Cloud-
Clone Corp) Organism Species (UK) according to the 
protocols attached to the sets using controls. To perform 
the analysis, a complex was used, including a Termo 
Scientific Multiskan GO enzyme-linked immunosorbent 
analyzer (Japan); washer Termo Scientific 112 Wellwash 
(Japan), shaker-thermostat Elmi ST-3L (Latvia).
Statistical processing of the findings Statistical 
processing of the findings was carried out by methods 
of variation statistics using Statistica 8.0 software. 
To compare the groups, the Kruskal-Wallis test was 
used, followed by a multiple analysis. The dynamics 
of markers in the postoperative period was evaluated 
using the Friedman test (ANOVA). Value p < 0.05 
was considered statistically significant. data are 
presented as median [interquartile range].
RESULTS
Data on changes in the osteoresorption marker 
are presented in Table 1. Blood level of CTX on the 
first day after surgery showed a slight or moderate 
increase in most of the animals included in the 
study, without significant differences between the 
groups. On the 3rd day after the operation, there was 
a sharp increase in the concentration of CTX in the 
blood in the β-TCP and PTI groups, in contrast, in 
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Table 1





р1Control RXM β-TCP NCI PTI
1 2 3 4 5
1 0 [0; 0] 5 [0; 70] 0 [0; 50] 10 [0; 70] 50 [30; 65] 0.301
3 10 [0; 40]2,5 18 [20; 265] 144 [125; 165]1,4 0 [0; 50]2,5 135 [120; 140]1,4 0.007
7 20 [0; 90] 113 [60; 190]4 112 [65; 123]4 0 [0; 0] 73 [50; 100]4 0.002
14 375 [350; 400] 110 [102; 240] 60 [50; 80]1 123 [0; 285] 70 [55; 80]1 0.002
45 0 [0; 50]4 63 [13; 355] 0 [0; 10]4 187 [100; 410]1,3,5 5 [0; 15]4 0.015
90 0 [0; 0]4 0 [0; 0]4 0 [0; 0]4 120 [120; 230]1,2,3,5 0 [0; 0]4 < 0.001
180 0 [0; 0] 4 0 [0; 0]4 0 [0; 0]4 140 [140; 210]1,2,3,5 0 [0; 0]4 < 0.001
р2 < 0.001 < 0.001 < 0.001 0.004 0.001
Note: results are presented as median [interquartile range]; р1 – statistical significance of differences between study groups; 1,2,3,4,5 – differences 
with groups 1, 2, 3, 4, 5 are statistically significant (p < 0.05); р2 – statistical significance of postoperative changes in the indicator in the group
Table 2





р1Control RXM β-TCP NCI PTI
1 2 3 4 5
1 11.5 [10.2;14.0] 24.3 [15.3; 29.2]4,5 10.0 [10.0; 13.0] 8.0 [7.0; 11.0]2 8.5 [7.0; 9.0]2 0.003
3 11.5 [9.6;14.0] 8.0 [7.5; 12.5] 12.0 [8.0; 15.0] 9.5 [9.0;11.0] 9.5 [8.0; 11.0] 0.473
7 16.7 [13.3; 23.0] 11.5 [9.0; 17.0] 19.0 [15.0; 22.0] 13.0 [11.0; 15.0] 12.0 [8.0; 13.0] 0.056
14 23.2 [21.6; 24.0]4 13.0[11.5;17.5] 35.0 [16.0; 53.0]4 8.0 [8.0; 10.0]1,3,5 18.0 [10.0; 29.0]4 0.010
45 10.0 [8.4; 12.0]3,5 11.5 [10.1; 14.5]3,5 26.5 [15.0;36.0]1,2 13.0[11.0; 15.0]5 25.0 [19.0;28.0]1,2 < 0.001
90 8.0 [7.4; 8.0]3 9.5 [8.0; 15.6] 13.0 [12.0;18.5]1,5 10.0 [7.0; 14.0] 8.0[5.0; 10.0]3 0.027
180 9.2 [7.0; 11.1] 8.5 [5.5; 11.0] 10.5 [8.0; 13.0] 8.0 [8.0; 13.0] 7.0 [5.0; 10.0] 0.462
р2 <0.001 0.001 <0.001 0.115 0.001
Note: results are presented as median [interquartile range]; р1 – statistical significance of differences between study groups; 1,2,3,4,5 – differences 
with groups 1, 2, 3, 4, 5 are statistically significant (p < 0.05); р2 – statistical significance of postoperative changes in the indicator in the group
the CG and NCI groups a low level remained, and 
in the RXM group there was a very wide variability 
of this marker. From day 7, the level of CTX tended 
to normalize in the β-TCP and PTI groups, in the 
RXM group, most animals showed an increase in 
this indicator; in the NCI group, the concentration of 
CTX was practically not detected. By day14, gradual 
normalization of the CTX concentration in the β-TCP 
and PTI groups continued; in the RXM group, a high 
level of resorption marker remained, and in the CG 
and NCI groups there was a sharp increase in the 
concentration of CTX in the blood. On day 45, the 
concentration of CTX in the β-TCP, PTI and CG 
groups continued to decrease, but remained high in 
the RXM and NCI groups. From day 90 until the end 
of the study, an increased level of bone resorption 
marker was maintained only in the NCI group.
An analysis of the dynamics of osteogenesis 
markers showed that the concentration of OC in the 
blood on day 1 after surgery was increased only in 
the RXM group (Table 2). On day 3, the level of OC 
in all experimental groups did not differ significantly 
from the value of this indicator in the group of control 
animals. From 7 days, an increase in this marker was 
detected in all the groups studied. By 14 days, the 
maximum level of OC was achieved in the β-TCP 
and CG groups, the lowest values of this indicator 
were in the NCI group. After 45 days, an elevated 
OC level remained in the β-TCP and PTI groups, 
by 90 days – only in the β-TCP group. By the end 
of the study period, the concentration of OC in any 
of the experimental groups did not exceed the level 
of the control group (Table. 2). It should be noted 
that in the NCI group, in contrast to other groups, 
postoperative changes in the OC concentration were 
not so pronounced (Friedman test, p = 0.115). 
The concentration of BALP in the control group 
gradually increased from the first week after surgery, 
reaching maximum values by 90 days. In the RXM, 
β-TCP and PTI groups, the concentration of this 
marker of osteogenesis increased more rapidly than 
in the control group and the enzyme level was higher, 
while the highest values were observed in the PTI 
group. In the NCI group, an increase in ALP was 
observed only in the earliest postoperative period, 
and it was apparently not associated with repair 
osteogenesis (Table 3).
The nature of changes in the concentration of CRP 
in the RXM, β-TCP and PTI groups corresponds to the 
dynamics of the postoperative period in the control 
group with an early recovery and gradual normalization 
to 90 days after surgery. However, in the NCI group, 
a significant increase in CRP levels persisted until the 
end of the study period (Table 4).
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Table 3




р1Control RXM β-TCP NCI PTI
1 2 3 4 5
1 8.2 [6.5; 9.4]3,4 11.8 [8.2; 15.1] 27.5 [18.0; 35.0]1 24.0 [19.0;30.0]1 6.9 [1.8; 13.0] 0.006
3 6.9 [6.6; 7.6] 11.6[11.6;11.9] 15.6 [7.3; 29.0] 17.8 [16.3;26.3]1 3.3 [2.1; 14.0] 0.023
7 14.1 [7.0; 24.7] 10.6 [8.2; 18.4]3 41.0 [32.0; 45.0]1,2,4 7.3 [5.1; 10.2]3 15.6 [6.4; 26.0] 0.010
14 12.1 [10.6; 13.4]5 14.8[12.0; 16.0]5 40.0 [27.0;54.0]1 14.5 [7.4; 40.0] 46.5 [38.0; 85]1,2 0.004
45 15.8 [14.7; 16.8]5 36.5 [32.0; 48.9] 26.0 [21.0;27.0]5 5.8 [5.7; 9.9]5 85.0 [64.0; 112.0]1,3,4 < 0.001
90 25.9 [24.1; 27.5]3,4 18.2 [16.0;24.5]4 14.2 [8.7; 17.3]1 9.1 [7.8; 9.8]1,2,5 18.4 [17.7; 21.0]4 < 0.001
180 14.6 [13.6; 15.5] 10.0 [8.9; 11.2] 10.0 [7.1; 14.0] 9.8 [8.9; 10.1]1 12.8 [10.9;14.3] 0.032
р2 < 0.001 < 0.001 < 0.001 0.004 < 0.001
Note: results are presented as median [interquartile range]; р1 – statistical significance of differences between study groups; 1,2,3,4,5 – 
differences with groups 1, 2, 3, 4, 5 are statistically significant (p < 0.05); р2 – statistical significance of postoperative changes in the 
indicator in the group
Table 4





р1Control RXM β-TCP NCI PTI
1 2 3 4 5
1 0.77 [0.73; 0.84] 0.70 [0.40;0.98] 1.45 [1.0; 1.60] 1.49 [1.00;1.53] 1.11 [1.00;1.20] 0.056
3 0.82 [0.66; 1.08] 0.99 [0.83;1.55] 1.30 [1.20;1.80] 1.76 [1.20;1.90] 1.22 [1.08;1.60] 0.054
7 0.58 [0.56; 0.62] 0.67 [0.42;0.84] 0.63 [0.56;1.25] 1.60 [0.55; 4.50] 0.58 [0.31;0.84] 0.627
14 0.21 [0.16;0.30]4 0.39 [0.33;0.41]4 0.42 [0.21;0.53]4 1.50 [0.63; 2.10]1,2,3,5 0.35 [0.12;0.54]4 0.003
45 0.03 [0.00;0.09]4 0.12 [0.03;0.36]4 0.21 [0.16;0.28]4 1.50 [0.65; 2.80]1,2,3,5 0.12 [0.11;0.24]4 0.001
90 0.00 [0.00; 0.00]4 0.00 [0.00;0.12]4 0.0 [0.0; 0.10]4 0.99 [0.70; 1.28]1,2,3,5 0.00 [0.00; 0.00]4 0.005
180 0.00 [0.00; 0.00]4 0.00 [0.00;0.04]4 0.00 [0.0; 0.00]4 0.46 [0.41; 0.58]1,2,3,5 0.00 [0.00; 0.00]4 < 0.001
р2 < 0.001 < 0.001 < 0.001 0.094 < 0.001
Note: results are presented as median [interquartile range]; р1 – statistical significance of differences between study groups; 1,2,3,4,5 – differences 
with groups 1, 2, 3, 4, 5 are statistically significant (p < 0.05); р2 – statistical significance of postoperative changes in the indicator in the group
dISCUSSION
The processes of bone resorption and bone 
formation after injuries and surgical interventions are 
accompanied by a change in blood levels of markers 
that reflect the functional activity of osteoclasts and 
osteoblasts performing bone remodeling [16, 17]. The 
C-terminal telopeptides of type I collagen split from its 
molecule and appear in the blood at the earliest stages 
of bone tissue destruction. In uncomplicated surgical 
treatment of fractures, the concentration of CTX begins 
to increase in the blood from week 1 after surgery, 
reaches the maximum by 4 to 8 weeks and returns to its 
original values by 24 weeks [18]. It is noted that the level 
and dynamics of osteoresorption markers is dependent 
on the volume of the injured tissue [12, 19]. We observed 
activation of bone resorption during the first two weeks 
after surgery in rabbits operated without implantation 
and augmentation with resorbable and non-resorbable 
materials, but the dynamics of this process were 
different. In β-TCP and PTI implantation, intensive 
bone resorption in experimental animals started earlier 
than in control animals, which apparently reflects the 
normal remodeling process during augmentation with 
these osteoplastic materials.
In the cases of RXM, the prolongation of CTX 
release into the blood is apparently associated with the 
influence of degradation of the collagen component 
of the implant itself. High level of bone degradation 
over a long period of time during augmentation using 
a carbon implant is obviously due to high intensity and 
duration of the inflammatory reaction that was found in 
this group of experimental animals in the postoperative 
period, since it is known that inflammation stimulates 
the process of bone resorption [13].
Osteocalcin refers to non-collagenic proteins, 
is expressed in the process of bone formation and 
controls the mass, size, orientation of the mineral 
component, participates in the organization of the 
extracellular matrix [20]. Previously, a large variety 
in the dynamics of OC after bone tissue damage 
was shown [17], which is also true for filling bone 
defects with various osteoplastic materials. The 
most pronounced and long-lasting, exceeding 
control values, increase in the concentration of this 
osteogenesis marker was observed by using β-TCP, 
which can serve as evidence of the effectiveness of 
the regenerative process. At the same time, a low 
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level of OC in NCI may indicate insufficient success 
in restoring bone tissue. An explanation of the early 
postoperative increase in OC level with the use of 
xenomaterial may be the incorporation of this protein 
into the bone matrix [21], which makes it possible 
to release it early in the RXM group. Low values of 
OC concentration in the subsequent time points of the 
study using RXM may be explained by insufficient 
activity of osteogenesis.
Bone isoenzyme of alkaline phosphatase is a 
tetrameric glycoprotein found on the cytoplasmic 
membrane of osteoblasts and has the ability to produce 
extracellular inorganic phosphorus. The level of ALP 
is considered to be associated with the level of bone 
formation [22]. A previous study on modeling a femoral 
diaphysis fracture in experimental animals showed an 
increase in the expression of informative RNA BALP in 
the period from 10 to 14 days. Clinical studies found a 
significant increase in the concentration of this marker in 
the blood 2–4 weeks after injury [14, 23], and the level of 
the marker may remain elevated even after consolidation 
of the fracture [24, 25]. However, violation of reparative 
osteogenesis after trauma leads to a less pronounced 
and/or later increase in the concentration of ALP in 
the blood compared with normal bone formation [26]. 
In our study, augmentation with osteoplastic materials 
led to an earlier and more pronounced increase in blood 
glucose concentration compared with surgery without 
augmentation, which may indicate a more effective 
regenerative process. An inflammatory reaction has 
a significant negative effect on bone remodeling 
[21]. In particular, high postoperative intensity of the 
inflammatory response inhibits the expression of ALP 
[27]. Apparently, it is precisely the high activity of 
the inflammatory process that explains the increased 
level of resorption markers and the reduced level of 
osteogenesis markers during augmentation of bone 
defects with nanostructured carbon implants.
CONCLUSION
Using a model of an impression fracture of 
the proximal tibia in rabbits, it was found that if a 
bone defect is filled in with resorbable β-TCP or 
nonresorbable PTI, a combination of a high level 
of osteogenesis markers and a low concentration of 
osteoclastic resorption marker indicates an active 
course of bone tissue reparative regeneration and 
effective integration of osteoplastic material in the 
area of an impression bone defect. Considering the 
obtained data, a porous titanium implant produced 
with additive 3D printing technology seems to be 
a promising augment for filling impression defects 
in intraarticular fractures. The use of xenoplastic 
material, augmented into the bone interface, did not 
show any advantages in comparison with surgery 
performed without augmentation. The nanostructured 
carbon implant did not possess osteogenesis-inducing 
properties, but its augmentation led to an increase 
in the processes of osteoclastic resorption. It can 
be assumed that the use of NCI for intraarticular 
fractures may result in a defect in the integration of 
augment and bone and worsen treatment results.
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